Tag: Compass Pathways

Psychedelic stocks are becoming just as popular with investors. All as drugs, like psilocybin show promise in treating a range of mental health issues, including  obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating disorders, depression and anxiety.  Better, the US FDA has already referred to psilocybin as “breakthrough therapy” and multiple studies are showing positive results.…